Atlas Trials

Metastatic Cutaneous Melanoma

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Cutaneous Melanoma

RecordFirmDate
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210)Fred Hutchinson Cancer Center2022-06-09
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases (NCT04511013)SWOG Cancer Research Network2021-01-06
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma (NCT04375527)Jonsson Comprehensive Cancer Center2020-12-03
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (NCT02506153)National Cancer Institute (NCI)2015-11-10
Drosophila-generated CTL (NCT01271907)National Cancer Institute (NCI)2011-04-15

Track Metastatic Cutaneous Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.